RFRobert Folberg

Robert Folberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert Folberg has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew J. Maniotis

    Department of Pathology, University of Illinois at Chicago, Chicago, Illinois

    10 shared publications
  • Amy Y. Lin

    Department of Pathology, University of Illinois at Chicago, Chicago, Illinois

    6 shared publications
  • Klara Valyi-Nagy

    Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA

    6 shared publications
  • Lu Leach

    Department of Pathology, University of Illinois at Chicago, Chicago, Illinois

    6 shared publications
  • Dibyen Majumdar

    From the Department of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, Illinois

    5 shared publications
  • Jacob Pe’eR

    Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and the

    4 shared publications

Latest Publications

  • 3D medical volume reconstruction using web services

    by Rob Kooper, Andrew Shirk, Sang-Chul Lee, Amy Lin, Robert Folberg, Peter Bajcsy


  • Open Access

    Using the Direct-Injection Model of Early Uveal Melanoma Hepatic Metastasis to Identify TPS as a Potentially Useful Serum Biomarker

    by Vivian Barak, Shahar Frenkel, Klara Valyi-Nagy, Lu Leach, Marsha A. Apushkin, Amy Y. Lin, Inna Kalickman, Nikola A. Baumann, Jacob Pe’eR, Andrew J. Maniotis, et al.

    Purpose. To develop a method to screen for serum biomarkers of early hepatic metastasis from uveal melanoma. methods. Cytokeratin 18 (TPS) was identified from gene expression profiles as protein generated by highly invasive uveal melanoma cells. Sera were collected from two groups of 15 SCID mice 2 weeks after injection of either tissue culture medium or MUM2B human metastatic uveal melanoma cells into the mouse liver. Serum TPS levels were assayed in 53 healthy human controls, 64 uveal melanoma patients who were disease free for at least 10 years, and 37 patients with metastatic uveal melanoma. results. After 2 weeks, small hepatic nodules (0.1–2.8 mm; mean, 0.80 mm) developed in 11 of 15 mice injected with MUM2B cells. Serum TPS levels in media-injected mice (84.7 U/L) were substantially lower than levels in MUM2B-injected mice (601 μg/L). TPS levels were significantly higher (P < 0.0001) in patients with metastatic uveal melanoma (139.63 ± 22.20) than in healthy controls (54.23 ± 0.01) or in patients free of disease (69.29 ± 9.76). Significant differences were found between TPS levels before and after the development of hepatic metastases (P < 0.01), and serum TPS levels became elevated in four patients at least 6 months before the detection of hepatic metastases by abdominal ultrasonography. conclusions. The direct-injection model of uveal melanoma in the mouse liver may be used to screen for potential serum biomarkers of metastatic uveal melanoma.


  • Open Access

    Modeling the Behavior of Uveal Melanoma in the Liver

    by Robert Folberg, Lu Leach, Klara Valyi-Nagy, Amy Y. Lin, Marsha A. Apushkin, Zhuming Ai, Vivian Barak, Dibyen Majumdar, Jacob Pe’eR, Andrew J. Maniotis

    Purpose. To model the behavior of uveal melanoma in the liver. methods. A 15-μL suspension of metastatic MUM2B or either primary OCM1 or M619 uveal melanoma cells was injected into the liver parenchyma of 105 CB17 SCID mice through a 1-cm abdominal incision. Animals were killed at 2, 4, 6, or 8 weeks after injection. Before euthanatization, 3% FITC-BSA buffer was injected into the retro-orbital plexus of one eye of three mice. Liver tissues were examined by light and fluorescence microscopy, and were stained with human anti-laminin. Vasculogenic mimicry patterns were reconstructed from serial laser scanning confocal microscopic stacks. results. OCM1a cells formed microscopic nodules in the mouse liver within 2 weeks after injection and metastasized to the lung 6 weeks later. By contrast, M619 and MUM2B cells formed expansile nodules in the liver within 2 weeks and gave rise to pulmonary metastases within 4 weeks after injection. Vasculogenic mimicry patterns, composed of human laminin and identical with those in human primary and metastatic uveal melanomas, were detected in the animal model. The detection of human rather than mouse laminin in the vasculogenic mimicry patterns in this model demonstrates that these patterns were of tumor cell origin and were not co-opted from the mouse liver microenvironment. conclusions. There are currently no effective treatments for metastatic uveal melanoma. This direct-injection model focuses on critical interactions between the tumor cell and the liver. It provides for translationally relevant approaches to the development of new modalities to detect small tumor burdens in patients, to study the biology of clinical dormancy of metastatic disease in uveal melanoma, to design and test novel treatments to prevent the emergence of clinically manifest liver metastases after dormancy, and to treat established uveal melanoma metastases.


  • Comparing Vasculogenic Mimicry With Endothelial Cell-lined Vessels: Techniques for 3D Reconstruction and Quantitative Analysis of Tissue Components from Archival Paraffin Blocks

    by Amy Y. Lin, Zhuming Ai, Sang-Chul Lee, Peter Bajcsy, Jacob Pe'Er, Lu Bs Leach, Andrew J. Maniotis, Robert Folberg

    We previously described techniques to generate 3-dimensional reconstructions of the tumor microcirculation using immunofluorescence histochemistry and laser scanning confocal microscopy on serial sections from archival formalin-fixed, paraffin-embedded tissues. By aligning sequential z-stacks in an immersive visualization environment (ImmersaDesk), the need to insert fiduciary markers into tissue was eliminated. In this study, we developed methods to stitch overlapping confocal z-series together to extend the surface area of interest well beyond that captured by the confocal microscope objective and developed methods to quantify the distribution of markers of interest in 3 dimensions. These techniques were applied to the problem of comparing the surface area of nonendothelial cell-lined, laminin-rich looping vasculogenic mimicry (VM) patterns that are known to transmit fluid, with the surface area of endothelial cell-lined vessels in metastatic uveal melanoma to the liver in 3 dimensions. After labeling sections with antibodies to CD34 and laminin, the surface area of VM patterns to vessels was calculated by segmenting out structures that labeled with laminin but not with CD34 from those structures labeling with CD34, or CD34 and laminin. In metastatic uveal melanoma tissues featuring colocalization of high microvascular density [66.4 microvessels adjusted for 0.313 mm2 area (range 56.7 to 72.7)] and VM patterning, the surface area of VM patterns was 11.6-fold greater (range 10.8 to 14.1) than the surface provided by CD34-positive vessels. These methods may be extended to visualize and quantify molecular markers in 3 dimensions in a variety of pathologic entities from archival paraffin-embedded tissues.


  • Tumor Cell Plasticity in Uveal Melanoma

    by Robert Folberg, Zarema Arbieva, Jonas Moses, Amin Hayee, Tone Sandal, ShriHari Kadkol, Amy Y. Lin, Klara Valyi-Nagy, Suman Setty, Lu Leach, et al.


  • Osteopontin Expression and Serum Levels in Metastatic Uveal Melanoma: A Pilot Study

    by ShriHari S. Kadkol, Amy Y. Lin, Vivian Barak, Inna Kalickman, Lu Leach, Klara Valyi-Nagy, Dibyen Majumdar, Suman Setty, Andrew J. Maniotis, Robert Folberg, et al.

    Purpose. This was a pilot study conducted to examine the expression of osteopontin in uveal melanoma and to determine whether serum osteopontin can be used in detecting metastatic uveal melanoma. methods. Osteopontin mRNA was measured in three uveal melanoma cell lines of various invasive potential by real-time PCR. Tissue sections of primary and metastatic uveal melanomas were stained for osteopontin. Serum osteopontin levels were measured by ELISA assays in 15 patients with metastatic uveal melanoma and in 37 patients who were disease-free for at least 10 years after treatment of the primary tumor. Paired serum samples drawn from eight patients before and after development of metastasis were analyzed. results. By real-time PCR, highly invasive primary and metastatic uveal melanoma cells expressed 6- and 250-fold excess osteopontin mRNA, respectively, compared with poorly invasive primary uveal melanoma cells. Tissue sections of primary uveal melanomas lacking looping vasculogenic mimicry patterns either did not stain for osteopontin or exhibited weak, diffuse staining. In primary melanomas containing looping vasculogenic mimicry patterns, strong osteopontin staining was detected in the tumor periphery where patterns were located. Diffuse strong expression of osteopontin was detected in eight samples of uveal melanomas metastatic to the liver. Serum osteopontin levels were significantly higher in patients with metastatic uveal melanoma than in patients who had been disease free for at least 10 years after treatment (P = 0.0001) or in age-matched control subjects. Serum osteopontin levels were significantly higher (P = 0.008) after metastasis than before the detection of metastasis in eight patients. When a cutoff of 10 ng/mL was used, the sensitivity and specificity of serum osteopontin in detecting metastatic melanoma was 87.5%, and the area under the receiver operator characteristic curve was 96%. conclusions. Osteopontin is expressed diffusely in tissue sections of hepatic metastases from uveal melanoma, and increased serum osteopontin levels correlate with melanoma metastasis to the liver with high specificity and sensitivity.


  • Open Access

    Distinguishing Fibrovascular Septa From Vasculogenic Mimicry Patterns

    by Amy Y. Lin, Andrew J. Maniotis, Klara Valyi-Nagy, Dibyen Majumdar, Suman Setty, Shri Hari Kadkol, Lu Leach, Jacob Pe'ER, Robert Folberg

    Context. —Molecular analyses indicate that periodic acid–Schiff (PAS)–positive (laminin-rich) patterns in melanomas are generated by invasive tumor cells by vasculogenic mimicry. Some observers, however, consider these patterns to be fibrovascular septa, generated by a stromal host response. Objective. —To delineate differences between vasculogenic mimicry patterns and fibrovascular septa in primary uveal melanomas. Design. —Frequency distributions, associations with outcome, and thicknesses of trichrome-positive and PAS-positive looping patterns were determined in 234 primary uveal melanomas. Sequential sections of 13 additional primary uveal melanomas that contained PAS-positive/trichrome-negative looping patterns were stained for type I and type IV collagens, laminin, and fibronectin. Real-time quantitative polymerase chain reaction was performed on RNA from cultured uveal melanoma cells for the expression of COL1A1, COL4A2, and fibronectin. Results. —Trichrome-positive loops were encountered less frequently than PAS-positive loops (10% vs 56%, respectively). Death from metastatic melanoma was strongly associated with PAS-positive ( P < .001) but not with trichrome-positive ( P = .57) loops. Trichrome-positive loops were significantly thicker than PAS-positive loops ( P < .001). The PAS-positive patterns stained positive for laminin, type I and type IV collagens, and fibronectin. Type I collagen was detected within melanoma cells and focally within some PAS-positive patterns. Real-time quantitative polymerase chain reaction revealed 3-fold, 25-fold, and 97-fold increases, respectively, in expression of COL4A2 , fibronectin, and COL1A1 by invasive pattern-forming primary melanoma cells compared with poorly invasive non– pattern-forming cells. Conclusions. —Fibrovascular septa are rare and prognostically insignificant in uveal melanomas, whereas vasculogenic mimicry patterns are associated with increased mortality. Type I collagen, seen focally in some vasculogenic mimicry patterns, may be synthesized by tumor cells, independent of a host stromal response.


  • Top Cited Papers

    Vasculogenic mimicry

    by Robert Folberg, Andrew J. Maniotis

    The term vasculogenic mimicry describes the formation of fluid‐conducting channels by highly invasive and genetically dysregulated tumor cells. Two distinctive types of vasculogenic mimicry have been described. Vasculogenic mimicry of the tubular type may be confused morphologically with endothelial cell‐lined blood vessels. Vasculogenic mimicry of the patterned matrix type in no way resembles blood vessels morphologically or topologically. Matrix proteins such as laminin, heparan sulfate proteoglycan, and collagens IV and VI have been identified in these patterns. The patterned matrix anastomoses with blood vessels, and systemically injected tracers co‐localize to these patterns. Vasculogenic mimicry of the patterned matrix type has been identified in uveal, cutaneous and mucous membrane melanomas, inflammatory and ductal breast carcinoma, ovarian and prostatic carcinoma, and soft tissue sarcomas, including synovial sarcoma rhabdomyosarcoma, osteosarcoma, and pheochromocytoma. Because the microcirculation of many tumors may be heterogeneous – including incorporated or co‐opted vessels, angiogenic vessels, mosaic vessels, and vasculogenic mimicry of the tubular and patterned matrix types – therapeutic regimens that target angiogenesis alone may be ineffective against highly invasive tumors that contain patterned matrices. Vasculogenic mimicry provides an opportunity to investigate the interrelationships between the genetically dysregulated invasive tumor cell, the microenvironment, and the malignant switch.